LUPIN
Quarterly Results Analysis [Sep2025]
LUPIN Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 Audited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 Audited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹7,048 Cr | ₹6,268 Cr | ₹5,667 Cr | ₹5,768 Cr | ₹5,673 Cr | ₹5,600 Cr | ₹4,961 Cr | ₹5,197 Cr |
| Expenses | ₹4,706 Cr | ₹4,541 Cr | ₹4,346 Cr | ₹4,412 Cr | ₹4,332 Cr | ₹4,359 Cr | ₹3,964 Cr | ₹4,159 Cr |
| Operating Income | ₹2,341 Cr | ₹1,727 Cr | ₹1,321 Cr | ₹1,356 Cr | ₹1,340 Cr | ₹1,241 Cr | ₹997 Cr | ₹1,038 Cr |
| Other Income | ₹90 Cr | ₹79 Cr | ₹57 Cr | ₹54 Cr | ₹42 Cr | ₹68 Cr | ₹29 Cr | ₹29 Cr |
| Interest | ₹108 Cr | ₹92 Cr | ₹89 Cr | ₹67 Cr | ₹71 Cr | ₹68 Cr | ₹71 Cr | ₹74 Cr |
| Depreciation | ₹317 Cr | ₹299 Cr | ₹393 Cr | ₹271 Cr | ₹257 Cr | ₹248 Cr | ₹457 Cr | ₹257 Cr |
| Profit Before Tax | ₹2,007 Cr | ₹1,416 Cr | ₹896 Cr | ₹1,071 Cr | ₹1,055 Cr | ₹993 Cr | ₹498 Cr | ₹736 Cr |
| Profit After Tax | ₹1,485 Cr | ₹1,221 Cr | ₹782 Cr | ₹859 Cr | ₹859 Cr | ₹806 Cr | ₹368 Cr | ₹619 Cr |
| EPS | ₹32.35 | ₹26.69 | ₹16.92 | ₹18.74 | ₹18.69 | ₹17.57 | ₹7.89 | ₹13.46 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| LUPIN | 0.4% | 2.4% | -11% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | 2.3% | -9.3% |
| DIVIS LABORATORIES | -1.3% | 9.1% | 16.7% |
| CIPLA | 0.2% | -0.6% | -3.8% |
| TORRENT PHARMACEUTICALS | 0.6% | 1% | 10.8% |
| DR REDDYS LABORATORIES | 0.6% | -3.5% | -4.3% |
| MANKIND PHARMA | -5% | -8.8% | -14.2% |
| ZYDUS LIFESCIENCES | -3.2% | -4.5% | -6.8% |
| AUROBINDO PHARMA | -1.4% | 3.1% | -18.6% |
LUPIN Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 12.43 % |
| Y-o-Y | 24.23 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹7,048 Cr | 12.43 | |
| Jun2025 | ₹6,268 Cr | 10.61 | |
| Mar2025 | ₹5,667 Cr | -1.74 | |
| Dec2024 | ₹5,768 Cr | 1.67 | |
| Sep2024 | ₹5,673 Cr | 1.29 | |
| Jun2024 | ₹5,600 Cr | 12.89 | |
| Mar2024 | ₹4,961 Cr | -4.55 | |
| Dec2023 | ₹5,197 Cr | - | |
LUPIN Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 35.55 % |
| Y-o-Y | 74.68 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹2,341 Cr | 35.55 | |
| Jun2025 | ₹1,727 Cr | 30.74 | |
| Mar2025 | ₹1,321 Cr | -2.56 | |
| Dec2024 | ₹1,356 Cr | 1.16 | |
| Sep2024 | ₹1,340 Cr | 8.01 | |
| Jun2024 | ₹1,241 Cr | 24.49 | |
| Mar2024 | ₹997 Cr | -3.96 | |
| Dec2023 | ₹1,038 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 20.58 % |
| Y-o-Y | 40.58 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 33.22% | 20.58 | |
| Jun2025 | 27.55% | 18.19 | |
| Mar2025 | 23.31% | -0.85 | |
| Dec2024 | 23.51% | -0.51 | |
| Sep2024 | 23.63% | 6.63 | |
| Jun2024 | 22.16% | 10.30 | |
| Mar2024 | 20.09% | 0.60 | |
| Dec2023 | 19.97% | - | |
LUPIN Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 21.56 % |
| Y-o-Y | 72.76 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹1,485 Cr | 21.56 | |
| Jun2025 | ₹1,221 Cr | 56.12 | |
| Mar2025 | ₹782 Cr | -8.90 | |
| Dec2024 | ₹859 Cr | -0.07 | |
| Sep2024 | ₹859 Cr | 6.70 | |
| Jun2024 | ₹806 Cr | 118.77 | |
| Mar2024 | ₹368 Cr | -40.48 | |
| Dec2023 | ₹619 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 8.11 % |
| Y-o-Y | 39.08 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 21.07 % | 8.11 | |
| Jun2025 | 19.49 % | 41.13 | |
| Mar2025 | 13.81 % | -7.25 | |
| Dec2024 | 14.89 % | -1.72 | |
| Sep2024 | 15.15 % | 5.35 | |
| Jun2024 | 14.38 % | 93.80 | |
| Mar2024 | 7.42 % | -37.65 | |
| Dec2023 | 11.9 % | - | |
LUPIN Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 21.21 % |
| Y-o-Y | 73.09 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹32.35 | 21.21 | |
| Jun2025 | ₹26.69 | 57.74 | |
| Mar2025 | ₹16.92 | -9.71 | |
| Dec2024 | ₹18.74 | 0.27 | |
| Sep2024 | ₹18.69 | 6.37 | |
| Jun2024 | ₹17.57 | 122.69 | |
| Mar2024 | ₹7.89 | -41.38 | |
| Dec2023 | ₹13.46 | - | |
You may also like the below Video Courses